First Patient Dosed in ATL1102 Phase IIb DMD Trial
Released
Latest announcements
Ask a question
Your question will be sent privately to Percheron Therapeutics. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Percheron Therapeutics a question about this announcement.